This is just getting started. VKTX just reported phase 1 results of their GLP1/GIP dual agonist. It appears effective in reducing liver fat (NASH), plasma lipips and weight. The side effects were mild to moderate.
I haven't looked at the code base, but any issues using this with fundamental data? Ideally, I would like to rank stocks based on reported items - retained earnings, sales, operating margins, etc.
Wouldn't the record label need to the identify the particular copy-write that was violated? The generated music is bound to be very much different then any individual piece.
If you're conversant in financial accounting, I can recommend https://www.portfolio123.com . They use Compustat data. However, building your own models will require significant effort, but it's worth it. I think of it as a site for the thinking investor.
Once Criterion (https://www.criterion.com/channel) goes online, it will be that + HBO for my main viewing needs. The other streaming services will get an occasional monthly subscription just for binging.
P123 maintains a record of simulated trades. Those trades are recorded at a price of trade day (High+low+2*Close)/4. They also make a slippage adjustment. Trade commissions are added under their Book system.
There isn't a direct link. You may find my models under Models->Designer Models (https://www.portfolio123.com/app/r2g) and then filter by my username - wwasilev.
I developed a trading model on https://www.portfolio123.com for my own personal use but that I later decided to open to subscribers. P123 calls them Designer Models and they're offered under a publishing model were subscribers assume responsibility for whether or not actual trades are made.